MedTrace Logo

Implementation of a Clinical Screening and Response System for Cardiac Complications After Noncardiac Surgery

NCT05859620 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 900

Last updated 2026-05-05

No results posted yet for this study

Summary

The investigators aim to show the feasibility and medicoeconomic impact of implementing a clinical screening and response system for the early detection of perioperative cardiac complications in high-risk patients.

Specifically, the investigators aim to: 1) evaluate the feasibility of implementation of a PMI-screening; 2) evaluate the medicoeconomic impact of implementing a PMI-screening; 3) identify barriers to implementation; 4) generate data for a future randomized controlled trial on outcomes by exploring opportunities to improve care following PMI, the occurrence and timing of major adverse cardiac events (MACE), and the treatment effect associated with PMI-screening.

Conditions

Interventions

OTHER

Patient assessment and follow-up

There is no study-specific intervention. The investigators will record data generated by clinical activity before, during and after implementation of the PMI-screening. Follow-up data and the final PMI event adjudication will be the only data generated specifically for this study.

Sponsors & Collaborators

  • Luzerner Kantonsspital

    collaborator OTHER

  • Kantonsspital Olten

    collaborator OTHER

  • Medical University Innsbruck

    collaborator OTHER

  • University Hospital, Geneva

    collaborator OTHER

  • Bürgerspital Solothurn

    collaborator OTHER

  • University Hospital, Basel, Switzerland

    lead OTHER

Principal Investigators

  • Christian Puelacher, MD-PhD · University Hospital, Basel, Switzerland

  • Christian Müller, Prof. · University Hospital, Basel, Switzerland

Eligibility

Min Age
40 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-01
Primary Completion
2026-12-31
Completion
2027-07-31

Countries

  • Austria
  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05859620 on ClinicalTrials.gov